dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

Core Viewpoint - dsm-firmenich has announced an increase in its share repurchase program to a total of €1.08 billion, following the completion of the sale of its stake in the Feed Enzymes Alliance [1][2]. Group 1: Share Repurchase Program Details - The initial share repurchase program was set at €500 million, which has now been increased to €1.08 billion [1][2]. - The program commenced on April 1, 2025, with an initial amount of €580 million allocated for repurchase, including €80 million for share-based compensation plans [2]. - The increased share repurchase program will be completed no later than January 30, 2026 [2]. Group 2: Execution and Compliance - The share repurchase will be executed in accordance with the Market Abuse Regulation and Swiss law [3]. - dsm-firmenich has engaged a bank to manage the execution of the share repurchase program independently [3]. Group 3: Current Status of Share Repurchase - As of the press release date, approximately 3.6 million ordinary shares have been repurchased, leaving around 8.1 million shares, or 3.0% of ordinary shares issued, still to be repurchased [4]. Group 4: Communication and Reporting - The company will provide weekly updates to the market regarding the progress of the share repurchase program [5].